The forecasted stability in the number of transluminal coronary angioplasty procedures performed in Canada, ranging from 85.3 to 85.4 thousand inpatient cases from 2024 to 2028, suggests a period of minimal annual growth. In 2023, the exact value is not provided, highlighting the size of this market. Year-on-year variation is almost non-existent, with only a slight increase anticipated in 2027-2028. This indicates a flat growth rate over the forecast horizon. The Compound Annual Growth Rate (CAGR) over the five years is negligible, reinforcing stability in the procedure's demand.
Future trends to watch for include potential technological advancements that enhance procedure efficiency and outcomes, which could boost demand. Additionally, changing demographics and healthcare policy reforms may impact the volumes of angioplasty procedures performed. Monitoring these factors is crucial for anticipating any shifts in this market.
- Minimal year-on-year variation with stable demand.
- A slight increase expected toward the end of the forecast period.
- A near-zero CAGR indicates flat growth over five years.
